Answers are grounded in this paper and cite their sources.
Due to the heterogeneity of the disease and regional treatment accessibility, complete standardization of AD management guidelines may be difficult. Nevertheless, more consensus on management guidelines is needed, and recommendations should be updated as new treatment modalities become available.
No takes yet. Share an insight, caveat, or question.
LePoidevin et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: